Hormone Replacement Therapy and Risk of Alzheimer’s Disease (Neurology)

Summary

A study by US researchers, and published in the Neurology journal, has linked hormone replacement therapy (HRT) in women to both an increased and a decreased risk of Alzheimer’s Disease, depending on the type of hormones used and the timing of the therapy.

The study examined whether the association of hormone therapy (HT) with Alzheimer’s Disease (AD) varies with timing or type of hormone replacement therapy use. The Cache County Study followed 1,768 women, between 1995 and 2006, who had provided a detailed history on age at menopause and use of HT. During this period, 176 women developed Alzheimer’s Disease.

Statistical analysis showed that women who used any type of HT within 5 years of menopause had a 30% lower risk of AD, especially if use was for 10 years or more. In contrast, risk of AD was not reduced among women who initiated HT 5 or more years after menopause.

The researchers conclude that the association between HT use and risk of AD may depend on the timing of use in relation to menopause. HT is apparently more beneficial if taken during a critical window near menopause, whereas HT (especially opposed compounds) initiated in later life may be associated with increased risk of women developing Alzheimer’s Disease. Further studies are required.

Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).

Reference

Shao, H. Breitner, JC. Whitmer, RA. [et al] (2012). Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study. Neurology, October 30th 2012, Vol.79(18), pp.1846-1852. (Click here to view the PubMed abstract).

Full Text Link (b) (Note: This article requires a suitable Athens password, a journal subscription or payment for access).

Reference

Henderson, VW. Rocca, WA. (2012). Estrogens and Alzheimer disease risk: Is there a window of opportunity? Neurology, October 30th 2012, Vol.79(18), pp.1840-1. (Click here to view the  PubMed record).

See also an earlier article:

Full Text Link (c)

Reference

Dye, RV. Miller, KJ. [and] Singer, EJ. [et al] (2012). Hormone replacement therapy and risk for neurodegenerative diseases. International Journal of Alzheimer’s Disease, Epub April 4th 2012. (Click here to view the PubMed abstract).

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.